The chemokine RANTES has been implicated in neointimal hyperplasia after arterial injury. We analyzed the differential role of the RANTES receptors CCR1 and CCR5 by genetic deletion in apolipoprotein E-deficient mice. Deficiency in CCR5 significantly reduced neointimal area after arterial wire-injury, associated with a decrease in macrophages, CD3 + T lymphocytes and CCR2 + cells. In contrast, CCR1 deficiency did not affect neointimal area or cell content. Deletion of CCR5 entailed up-regulation of the anti-inflammatory cytokine interleukin-10 in neointimal smooth muscle cells, and its antibody blockade reversed effects in CCR5 -/-mice. Conversely, pro-inflammatory interferon-γ was increased in the neointima of CCR1 -/-mice, and its blockade unmasked a reduction in macrophage recruitment. Our data indicate that CCR5 is more crucial than CCR1 for neointimal formation, and that its attenuation in CCR5
Introduction
Neointima formation in response to arterial injury or during accelerated atherosclerosis involves leukocyte recruitment and pro-inflammatory cytokines, which sustain neointimal growth and progression 1 . A key role herein can be ascribed to chemokines, which mediate immigration and activation of mononuclear cells via heptahelical receptors 2, 3 . Blocking the receptors of the chemokine RANTES/CCL5 with a peptide antagonist has been shown to inhibit lesion formation and macrophage infiltration during native atherogenesis 4 and after arterial injury 5 .
The balance between cytokines of type-1 and type-2 T helper (Th) cells critically determines plaque inflammation and progression 6 . Engagement of distinct RANTES receptors can produce specific functions to differentially modulate immune responses: whereas CCR1
mediates monocyte and T cell arrest triggered by RANTES on activated endothelium, CCR5
mainly supports migration 5, [7] [8] [9] . CCR5 is required for the Th1-cell-selective transmigration induced by endothelial RANTES 9 and its deletion results in a Th2-type immune response 10 , whereas a lack of CCR1 enhances Th1-type responses 11, 12 . Emulating arterial injury in the context of atherosclerosis, we dissected the involvement of CCR1 and CCR5 in neointima formation and underlying immune mechanisms in apoE -/-mice lacking either receptor. 
Intracellular cytokine staining
For intracellular cytokine staining 14, 15 , mononuclear splenocytes were isolated from meshed spleens by Ficoll. After stimulation with PMA (50ng/mL) in RPMI-1640/10% FCS (10µg/mL Brefeldin A, 500ng/mL ionomycin) for 4h at 37°C, cells were fixed, permeabilized, stained with anti-CD4-FITC and anti-IL-10-PE or anti-IFN-γ-PE Ab (Pharmingen), and analyzed with a FACSCalibur (Becton Dickinson).
Statistical analysis

Data represent mean±SEM. Statistical analysis was performed using Student's-t test. P-values
<0.05 were considered significant.
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Results and Discussion
Compared to CCR5
+/+ apoE -/-mice, CCR5 -/-apoE -/-mice showed a striking reduction in neointima (by 63%) after wire-injury of the carotid artery ( Figure 1A) , as confirmed by expressing areas as percentage of total vessel area to correct for tangential sections (Table 1A) . No differences in arterial size, medial area, body weight or lipid levels were seen (Table 1A , not shown). The decrease in neointimal area was associated with alterations in cellular composition. Figure 1C) . Thus, the more stable plaque phenotype is primarily attributable to reduced mononuclear cell infiltration. In contrast, genetic deletion of CCR1 in apoE -/-mice did not affect body weight, lipid levels, arterial size, neointimal or medial area or cell content ( Figure 1A ,B, Table 1B , not shown). Blocking or genetic deletion of CCR1 or CCR5
did not affect SMC migration or proliferation in vitro (not shown).
The identification of CCR5 as the crucial RANTES receptor refines data that a global receptor antagonist inhibits neointima formation, atherogenesis and macrophage infiltration in hyperlipidemic mice 4, 5 . Accordingly, reduced neointima formation and T cell content was seen in arteries allografted into CCR5 -/-recipients 16 , whereas disruption of CCR5 in apoE -/-mice failed to protect from spontaneous atherogenesis at least in early stages 17 . These differences may be related to the acute inflammatory component or the severity of injury in transplant-and wireinduced arteriopathy. Figure) , suggesting that differences observed in our wire-injury model are also relevant to native atherosclerosis. Our data are consistent with reports that individuals homozygous for a CCR5 deletion allele are at reduced risk for advanced coronary artery disease 19, 20 .
Immunofluorescence staining further revealed a neointimal up-regulation of the Th1-associated cytokine INF-γ in CCR1 -/-apoE -/-mice, while INF-γ was hardly detectable in control groups or CCR5 -/-apoE -/-mice. In contrast, the Th2-associated cytokine IL-10 was present in the neointima of both control groups or CCR1 -/-apoE -/-mice, and increased in CCR5 -/-apoE -/-mice (Table 1 ). Double immunofluorescence revealed that increased expression of IL-10 in CCR5
-/-apoE -/-mice originates from neointimal SMCs rather than macrophages ( Figure 1D , not shown), consistent with findings in advanced human plaques 21 .
Systemic effects of CCR1 and CCR5 deletion on the Th1/Th2 balance were confirmed by flow cytometric analysis of IL-10 and IFN-γ in CD4 + splenocytes (Table 1) Figure 1A ,B). Isotype controls had no effect (not shown). Thus, the shift towards a Th2-type immune response with increased IL-10 expression appears to account for the reduced neointima formation in CCR5 -/-mice.
The balance of pro-and anti-inflammatory cytokines has emerged as a crucial determinant in atherogenesis 6 . Whereas IFN-γ potentiates atherosclerosis, IL-10 and other Th2-cytokines (e.g. IL-4, IL-5) can exert protective functions 15, [22] [23] [24] [25] . Lack of CCR5 known as a Th1-cell marker was associated with increased lesional IL-10 expression, corresponding with a systemic shift towards a Th2-type immune response 10 . While the reduction of neointimal area in CCR5 -/-mice was completely reversed by systemic IL-10 blockade and thus attributable to IL-10 expression, the decrease in macrophage infiltration was only partially reversed, and possibly sustained by a defect in CCR5-mediated recruitment of Th1-type cells 8 . Despite an increase in lesional IFN-γ concurrent with a systemic shift towards a Th1-response in CCR1 -/-mice 12 , deletion of CCR1 did not alter neointimal area or composition. While a lack of CCR1 enhanced Th1-immune responses aggravating nephrotoxic nephritis 11 , our finding that blocking IFN-γ unveiled a decrease in macrophage content infers that Th1-related inflammatory mechanisms are balanced by defects in CCR1-mediated functions in vascular cell recruitment.
In conclusion, lack of CCR5 but not CCR1 exerts non-redundant protective effects on neointima formation. This appears to be due to a shift towards a Th2-type immune response involving IL-10 expression. Therefore, blocking CCR5 but not CCR1 may be a suitable strategy for interfering with arterial remodeling in the context of atherosclerosis. For personal use only. on October 28, 2017. by guest www.bloodjournal.org From
